An independent advisory committee to the Food and Drug Administration on Tuesday narrowly endorsed the first antiviral pill for Covid-19 in a 13-10 vote.
The Merck-Ridgeback Biotherapeutics pill can be taken at home and can cut hospitalization rates by about 30 percent, according to available data.
Some panel member voiced concerns over the efficacy of the treatment, and possible risks to individuals who are pregnant or nursing.
